Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic bilastine 20 mg vs Bilaxten in healthy Thai volunteers (fasting, single-dose, crossover)
TCTR20240429001Phase 0Unknown
- Sponsor
- MacroPhar
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of bilastine in allergic rhinitis (AR) and chronic urticaria (CU) (2 arms), sponsored by MacroPhar. Status: unknown.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)chronic urticaria (CU)
Beyond the preview
Go deeper on TCTR20240429001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240429001.